Pfizer Inc. (PFE.DE) Stock Overview
Explore Pfizer Inc.’s financial performance, market position, analyst ratings, and future outlook.
Pfizer Inc. (PFE.DE)
Key Financials
Key Financials
Market Cap
140.3B
P/E Ratio
36.46
EPS (TTM)
$2.32
ROE
0.05%
PFE.DE Stock Analysis & Investment Overview (XETRA)
Our AI-powered analysis of Pfizer Inc. (XETRA: PFE.DE) gives investors deep insight into how the stock performs on the XETRA exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Pfizer Inc.'s XETRA-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of PFE.DE on the XETRA shows an RSI of 53.85, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $25.26 for the XETRA listing.
Key metrics behind Pfizer Inc.'s XETRA-traded stock include a P/E ratio of 36.46 and a market capitalization of 140.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PFE.DE on the XETRA.